Thyroid hormones were demonstrated to upregulate the synthesis of epid
ermal growth factor (EGF) mRNA and proEGF in the kidneys in vivo. This
prospective study was performed to examine the extent of the hypothyr
oid state in modulating EGF excretion in the urine (U-EGF; n = 23). Pa
tients with thyroid cancer were serially followed up from the euthyroi
d status, which was retained by thyroxine supplement after thyroidecto
my, to the hypothyroidism in preparing for I-131 whole body scanning.
Paired thyroid function panel, Including triiodothyronine (T-3), thyro
xine (T-4), thyroid-stimulating hormone (TSH), and U-EGF levels were m
easured on a weekly basis. Logarithmically transformed values of U-ECF
were inversely correlated with TSH serum levels (p = 0.0000), but pos
itively associated with T-4 levels (p = 0.0005). No apparent correlati
on was observed with the T-3 serum content, age and gender of the pati
ents (p > 0.1, respectively). If the interval of measurement was taken
into consideration, serum TSH was the most significant factor in asso
ciation with U-EGF (p = 0.0003). Our data indicate that excretion of E
GF in human urine depends substantially upon thyroid hormone support.